Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Follow up complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1 clinical trial to evaluate the safety and immunogenicity of orally-administered replication-competent Adenovirus type-4 HIV vaccine regimens in healthy, HIV-uninfected adult participants
Description
HVTN 110 is a Phase I clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of Ad4-mgag (Ad4), Ad4-EnvC150 (Ad4), and AIDSVAX B/E.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.